Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
about
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosisEradication therapy for Burkholderia cepacia complex in people with cystic fibrosisVolatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapyPseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatmentFluorescent DNA chemosensors: identification of bacterial species by their volatile metabolitesLow rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.Mucosal vaccination against bacterial respiratory infections.Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.Aerosolized antibiotics in cystic fibrosis: current and future trends.External fistulous wound with Pseudomonas aeruginosa infection and massive bleeding following rupture of pulmonary suppuration.Hypertonic Saline Therapy in Cystic Fibrosis: Do Population Shifts Caused by the Osmotic Sensitivity of Infecting Bacteria Explain the Effectiveness of this Treatment?The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
P2860
Q24193082-C20A6840-055C-40DB-9551-7DD1B3981C5DQ24198175-1E64E9FD-A8FF-4E25-A106-141AFA34F31DQ31004494-74508892-CE41-497D-A871-BEF54E7FDA93Q33654992-D99A8FDE-7A09-4CC4-A896-16F333E3EE88Q33697276-66027DF9-F518-473F-B855-E51FBBD792FCQ33824149-727AF7FC-FCE0-4238-BF27-B1B0CC1AA4C4Q33862895-50DA7084-53D2-46AA-BDEC-0AD4F08DD6CBQ34956792-74A76D0D-C908-4D1B-A853-B703C217B6E2Q35630919-3B2B6C10-3D5C-4BCE-B89F-FDEEAAA57C5CQ37290114-B8AFCD74-3B15-458A-9AE6-78129F64117DQ38996423-BE494835-D6B6-4B57-A842-3CC00AD05662Q40065026-E519444D-669A-464D-BBCC-C1DD6163BAC5Q41843728-09681374-DB8B-4B13-91A5-018D8645C52FQ42732058-DC2E6D1B-5018-4A5B-B24F-E6A06840D3F0Q43489716-D24B1EFA-046B-41A3-8FB7-C5058CB4D973
P2860
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@ast
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@en
type
label
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@ast
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@en
prefLabel
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@ast
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
@en
P1476
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis
@en
P2093
Felix Ratjen
P304
P356
10.1097/01.MCP.0000245712.51514.A1
P50
P577
2006-11-01T00:00:00Z